Ondine Biomedical Inc.

9.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:OBIHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 5Y CAGR (31.25%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.35
PE TTM —
TSR TTM (32.08%)
Mkt cap £50.51M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
9.46p
5.15%
(51.96%)
Hold 8|6|10|9|9
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.19
0.21
0.22
0.23
31.17%
43.07%
40.50%
32.40%
Revenue$M
3.178
3.331
3.326
3.404
(2.68%)
2.83%
3.21%
5.07%
Peers (US$67.96M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.669
—
—
EBIT/Intx
2.149
0.114
0.131
Own earn%
(463.16)
73.71
52.93
Sh yield%
29.66
22.46
18.40
Owners
Insiders/Inst%
10.72
43.98
Short interest%
4.97
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
19–29
$1 testx
0.5
Incr. ROIC%
66